Blood cancer incidence and survival by histology (experimental data)
The blood cancer incidence and survival and histology data survival and incidence visualisations have been broken into 2 separate reports. The first set of visualisations, referred to as the main reporting framework, represents the blood cancer reporting framework that has been mapped with the knowledge and assistance of the Leukaemia Foundation Blood Cancer Taskforce. The second set of visualisations, referred to as ICD-10, uses the structure of blood cancers from the main reporting framework and applies it to the ICD-10 based reporting which is more commonly used elsewhere within the CdiA.
The primary reason for applying the blood cancer by histology to the ICD-10 structure is to allow finer level understandings and reporting of the blood cancers reported elsewhere within the Cancer data in Australia report. Cancer data commentary 10 provides more information about the blood cancer by histology reporting, including why the data is experimental. The ICD-10 blood cancer by histology visualisations follow the main reporting.
The following cancer incidence and survival data visualisations have been developed with the assistance of the Leukaemia Foundation Blood Cancer Taskforce. We thank the taskforce for their time and expert knowledge, without which, the blood cancer histology reporting used below would not be available.
Figure 1 of this visualisation shows incidence rates by age time series for the selected blood cancer. Figure 2 shows the time series of percentages that the blood cancer type is of the selected blood cancer group. Rates and percentages are available for different age groups and overall. The visualisation contains information on many different blood cancers. Data is available by sex. The data for this visualisation is available in Excel workbooks in the Data section of the Cancer data in Australia report.
Blood cancer incidence by histology data are available as supplementary tables.
Blood cancer survival by histology (main)
The number of blood cancer types available within the survival visualisation is less than incidence. Incidence data is provided if there is at least one case in the years reported while survival rates are provided if there is a survival rate for at least one of the reporting periods. Reliable survival rates require considerably more cases.
In addition to the 5-year reporting periods, a 15-year reporting period (2005–2019) has been created to increase the likelihood of at least a limited range of survival statistics being available for rarer cancers. This period provides only a limited understanding of survival. A limitation of this period is that the rates may be more predominantly derived from earlier years where survival may differ compared to more recent periods.
Figure 1 of this visualisation shows the survival rates for the selected blood cancer over time. Figure 2 shows the survival rates by age for the selected type for the most recent 15-year period. Figure 3 shows the proportion of cases by age for the selected blood cancer. Survival rates include either relative or observed. Survival rates include 1, 2-, 3-, 4- or 5-year survival. Data is available by sex. The data for this visualisation is available in Excel workbooks in the Data section of the Cancer data in Australia report.
Blood cancer incidence by histology data are available as supplementary tables.
Cancer sites within the Cancer data in Australia report are generally derived using the International Classification of Diseases 10th Revision (ICD-10). The blood cancer by histology reporting (ICD-10) uses the main blood cancer reporting structure and applies it to the blood cancer reporting used within the ICD-10. It is provided primarily for those using the blood cancer reporting structure used elsewhere in this report of the composition of these cancers and how survival rates may vary depending on histological differences.
Blood cancer incidence by histology (ICD-10)
Figure 1 of this visualisation shows incidence rates by age time series for the selected blood cancer. Figure 2 shows the time series of percentages that the blood cancer type is of the selected ICD-10 derived blood cancer group. Rates and percentages are available for different age groups and overall. The visualisation contains information on many different blood cancers. Data is available by sex. The data for this visualisation is available in Excel workbooks in the Data section of the Cancer data in Australia report.
Blood cancer incidence by histology data are available as supplementary tables.
Blood cancer survival by histology (ICD-10)
The number of blood cancers available within the blood cancer survival by histology survival visualisation is less than incidence. Incidence data is provided if there is at least one case in the years reported while survival rates are provided if there is a survival rate for at least one of the reporting periods. Reliable survival rates require considerably more cases.
In addition to the 5-year reporting periods, a 15-year reporting period (2005–2019) has been created to increase the likelihood of at least a limited range of survival statistics being available for rarer cancers. This period provides only a limited understanding of survival. A limitation of this period is that the rates may be more predominantly derived from earlier years where survival may differ compared to more recent periods.
Figure 1 of this visualisation shows the survival rates for the selected blood cancer over time. Figure 2 shows the survival rates by age for the selected type for the most recent 15-year period. Figure 3 shows the proportion of cases by age for the selected blood cancer. Survival rates include either relative or observed. Survival rates include 1, 2-, 3-, 4- or 5-year survival. Data is available by sex. The data for this visualisation is available in Excel workbooks in the Data section of the Cancer data in Australia report.
Blood cancer survival by histology data are available as supplementary tables.